The role of the Theratechnologies Hybrid Medical Science Liaison (MSL) is pivotal, embodying a
specialized, field-oriented expertise in the realm of HIV therapeutics, through support of ibalizumab,
tesamorelin and crofelemer.
Adhering rigorously to regulatory and corporate directives, the MSL will adeptly foster and nurture
scientific partnerships within the relevant scientific communities. This critical role entails engaging
with designated Key Opinion Leaders (KOLs) and healthcare practitioners (HCPs) at national,
regional, and local levels.
Reporting to the EVERSANA National Director-Head of Field Medical for Thera/FuturePak, the Hybrid
Medical Science Liaison (hMSL) is a Medical Affairs professional that will serve as an external
scientific representative of Theratechnologies engaging with Key Opinion Leaders (KOLs) and
Healthcare Professionals HCPs). The hMSL position is a hybrid role that will support Field Medical
capabilities in both a virtual, and in some instances, face-to-face capacity. The hMSL will develop and
maintain proactive relationships with designated KOLs and assigned institutions to provide compliant,
proactive scientific education for in-line products, in person and virtually in full alignment with Medical
Affairs strategies and tactics. The hMSL will provide reactive responses to unsolicited requests for
medical information from medical professionals on an ad hoc basis and in compliance with corporate
policies and procedures, and US healthcare laws and regulations. The hMSL will collaborate with
peers to ensure timely fulfillment of these requests during all business hours.
The hMSL will contribute to the development of Medical Advocates through compliant proactive,
virtual disease state and safety and efficacy education. The hMSL will also represent
Theratechnologies in person at medical and scientific conferences The hMSL will carry out proactive
assignments as outlined by the National Director in which he/she will be responsible for establishing
professional relationships with KOLs and conducting unbiased scientific interactions related to
relevant disease states and scientific topics of interest, as well as company products.
The successful candidate will exhibit outstanding professional communication skills along with a high
degree of scientific and industry expertise. Senior hMSLs will have at least 4 years of MSL
experience and will demonstrate a high degree of familiarity with regulatory guidelines and industry
standards related to scientific medical engagement and scientific engagement. hMSLs will be
equipped with 0–2 years’ experience in pharma/biotech OR relevant clinical/practice/research
background with strong communication skills and high learning agility who express professional
presence with KOLs despite limited experience.